My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1309

    1.

    Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.

    Huurman VA, Kalpoe JS, van de Linde P, Vaessen N, Ringers J, Kroes AC, Roep BO, De Fijter JW.

    Diabetes Care. 2006 Apr;29(4):842-7.PMID: 16567825 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.

    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L; Euro-SPK Study Group.

    Nephrol Dial Transplant. 2005 May;20 Suppl 2:ii25-ii32, ii62.PMID: 15814546 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.

    van de Linde P, Vd Boog PJ, Tysma OM, Elliott JF, Roelen DL, Claas FH, de Fijter JW, Roep BO.

    Clin Exp Immunol. 2007 Jul;149(1):56-62. Epub 2007 Apr 25.PMID: 17459076 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Single-shot antithymocyte globuline and daclizumab induction in simultaneous pancreas and kidney transplant recipient: three-year results.

    Schulz T, Flecken M, Kapischke M, Busing M.

    Transplant Proc. 2005 May;37(4):1818-20.PMID: 15919476 [PubMed - indexed for MEDLINE]Related articles

    5.

    Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.

    Becker BN, Becker YT, Leverson GE, Simmons WD, Sollinger HW, Pirsch JD.

    Am J Kidney Dis. 2002 May;39(5):1088-95.PMID: 11979354 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results.

    Burke GW 3rd, Kaufman DB, Millis JM, Gaber AO, Johnson CP, Sutherland DE, Punch JD, Kahan BD, Schweitzer E, Langnas A, Perkins J, Scandling J, Concepcion W, Stegall MD, Schulak JA, Gores PF, Benedetti E, Danovitch G, Henning AK, Bartucci MR, Smith S, Fitzsimmons WE.

    Transplantation. 2004 Apr 27;77(8):1269-75.PMID: 15114097 [PubMed - indexed for MEDLINE]Related articles

    7.

    A comparison of daclizumab to ATGAM induction in simultaneous pancreas-kidney transplant recipients on triple maintenance immunosuppression.

    Rasaiah SB, Light JA, Sasaki TM, Currier CB.

    Clin Transplant. 2000 Aug;14(4 Pt 2):409-12.PMID: 10946780 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients.

    Humar A, Uknis M, Carlone-Jambor C, Gruessner RW, Dunn DL, Matas A.

    Transplantation. 1999 Jan 15;67(1):94-7.PMID: 9921803 [PubMed - indexed for MEDLINE]Related articles

    9.

    Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.

    Brennan DC, Garlock KA, Lippmann BA, Buller RS, Gaudreault-Keener M, Lowell JA, Miller SB, Shenoy S, Howard TK, Storch GA.

    J Am Soc Nephrol. 1997 Jan;8(1):118-25.PMID: 9013456 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.

    Turgeon N, Fishman JA, Basgoz N, Tolkoff-Rubin NE, Doran M, Cosimi AB, Rubin RH.

    Transplantation. 1998 Dec 27;66(12):1780-6.PMID: 9884276 [PubMed - indexed for MEDLINE]Related articles

    11.

    Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation.

    Kaufman DB, Leventhal JR, Gallon LG, Parker MA, Koffron AJ, Fryer JP, Abecassis MM, Stuart FP.

    Transplantation. 2001 Dec 27;72(12):1940-5.PMID: 11773893 [PubMed - indexed for MEDLINE]Related articles

    12.

    Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.

    Cantarovich D, Karam G, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Le Normand L, Soulillou JP.

    Kidney Int. 1998 Oct;54(4):1351-6.PMID: 9767555 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.

    Deeks ED, Keating GM.

    Drugs. 2009;69(11):1483-512. doi: 10.2165/00003495-200969110-00007. Review.PMID: 19634926 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.

    Pouteil-Noble C, Ecochard R, Bosshard S, Lacavalerie B, Donia A, Landrivon G, Tardy JC, Dubernard JM, Aymard M, Touraine JL.

    Transpl Int. 1992;5 Suppl 1:S26-9.PMID: 14621724 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients.

    Axelrod D, Leventhal JR, Gallon LG, Parker MA, Kaufman DB.

    Am J Transplant. 2005 Jun;5(6):1423-9.PMID: 15888050 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cytomegalovirus infection in simultaneous pancreas-kidney transplantation.

    Malaise J, Ricart MJ, Moreno A, Crespo M, Fernández-Cruz L, Van Ophem D, Squifflet JP; EUROSPK Study Group.

    Transplant Proc. 2005 Jul-Aug;37(6):2848-50.PMID: 16182830 [PubMed - indexed for MEDLINE]Related articles

    17.

    The effect of polyimmune gammaglobulin for prophylaxis against reactivation cytomegalovirus infection in kidney and kidney/pancreas transplant recipients.

    McCune TR, Johnson HK, MacDonell RC Jr, Richie RE, Nylander WA, Van Buren DH, Helderman JH.

    J Am Soc Nephrol. 1992 Apr;2(10):1469-74.PMID: 1376177 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.

    Kalpoe JS, Schippers EF, Eling Y, Sijpkens YW, de Fijter JW, Kroes AC.

    Antivir Ther. 2005;10(1):119-23.PMID: 15751769 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation.

    Abou-Jaoude MM, Ghantous I, Almawi WY.

    Mol Immunol. 2003 Jul;39(17-18):1083-8.PMID: 12835081 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.

    Rayes N, Seehofer D, Kahl A, Kokott S, Pratschke J, Frei U, Neuhaus P.

    Transpl Int. 2007 Nov;20(11):974-81. Epub 2007 Aug 2.PMID: 17680782 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity